Nuformix plc (NFX) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.242x

Based on the latest financial reports, Nuformix plc (NFX) has a cash flow conversion efficiency ratio of -0.242x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-395.35K ≈ $-48.10 USD) by net assets (GBX1.64 Million ≈ $199.11 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Nuformix plc market capitalisation for the company's overall valuation and market capitalisation.

Nuformix plc - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Nuformix plc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Nuformix plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nuformix plc ranked by their cash flow conversion efficiency. Explore Nuformix plc cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Allianz Malaysia Bhd KLSE:1163PA	-0.070x
Alba Mineral Resources LSE:ALBA	-0.053x
Vox Valor Capital Ltd. LSE:VOX	-0.001x
Westmount Energy Limited LSE:WTE	0.000x
Chess Depositary Interests 1:1 Deferred Settlement AU:AIIDA	N/A
Jereissati Participações S.A. SA:IGTI11	0.029x
URU Metals Ltd LSE:URU	0.261x
Surgical Innovations Group plc LSE:SUN	0.106x

Annual Cash Flow Conversion Efficiency for Nuformix plc (2014–2025)

The table below shows the annual cash flow conversion efficiency of Nuformix plc from 2014 to 2025. View NFX stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-09-30	GBX754.93K ≈ $91.85	GBX-614.61K ≈ $-74.78	-0.814x	-75.53%
2024-09-30	GBX715.57K ≈ $87.06	GBX-331.88K ≈ $-40.38	-0.464x	-256.20%
2023-09-30	GBX4.20 Million ≈ $510.41	GBX-546.23K ≈ $-66.46	-0.130x	-27.12%
2023-03-31	GBX4.23 Million ≈ $514.45	GBX-433.10K ≈ $-52.70	-0.102x	+63.94%
2022-03-31	GBX4.74 Million ≈ $576.47	GBX-1.35 Million ≈ $-163.73	-0.284x	-90.40%
2021-03-31	GBX5.69 Million ≈ $691.85	GBX-848.22K ≈ $-103.20	-0.149x	+2.77%
2020-03-31	GBX4.74 Million ≈ $577.03	GBX-727.60K ≈ $-88.53	-0.153x	-95.54%
2019-03-31	GBX3.82 Million ≈ $464.22	GBX-299.34K ≈ $-36.42	-0.078x	+76.98%
2018-03-31	GBX4.49 Million ≈ $546.69	GBX-1.53 Million ≈ $-186.31	-0.341x	-112.33%
2017-03-31	GBX-179.59K ≈ $-21.85	GBX-496.32K ≈ $-60.39	2.764x	+496.03%
2016-03-31	GBX502.34K ≈ $61.12	GBX-350.55K ≈ $-42.65	-0.698x	-89021.82%
2015-07-31	GBX-110.86K ≈ $-13.49	GBX86.80 ≈ $0.01	-0.001x	-224.10%
2014-07-31	GBX247.00K ≈ $30.05	GBX155.85 ≈ $0.02	0.001x	--

About Nuformix plc

LSE:NFX UK Biotechnology

Market Cap

$49.22K

GBX404.51 Million GBX

Market Cap Rank

#31640 Global

#1211 in UK

Share Price

GBX0.16

Change (1 day)

+0.00%

52-Week Range

GBX0.11 - GBX0.49

All Time High

GBX13.75